Table 2

 Immunostaining of hepatocellular (HCC) and non-hepatocellular (non-HCC) carcinomas

HCCNon-HCC
Total n/n (%)G1 n/n (%)G2 n/n (%)G3 n/n (%)n/n (%)
AFP, α fetoprotein; CD13, aminopeptidase N, p-CEA; antibody that crossreacts with biliary glycoprotein I.
CD13
    Cytoplasm9/53 (17.0)0/148/35 (22.9)1/4 (25.0)1/32 (3.1)
    Cell membrane (non-canalicular)6/53 (11.3)3/14 (21.4)2/35 (5.7)1/4 (25.0)1/32 (3.1)
    Cell membrane (canalicular)51/53 (96.2)14/1434/35 (97.1)3/4 (75.0)1/32 (3.1)
p-CEA
    Cytoplasm13/53 (24.5)2/14 (14.3)9/35 (25.7)2/4 (50.0)16/32 (50.0)
    Cell membrane (non-canalicular)14/53 (26.4)4/14 (28.6)8/35 (22.9)2/4 (50.0)7/32 (21.9)
    Cell membrane (canalicular)43/53 (81.1)10/14 (71.4)31/35 (88.6)2/4 (50.0)0/32
CD10
    Cytoplasm30/53 (56.6)10/14 (71.4)18/35 (51.4)2/4 (50.0)10/32 (31.3)
    Cell membrane (non-canalicular)8/53 (15.1)4/14 (28.6)3/35 (8.6)1/4 (25.0)4/32 (12.5)
    Cell membrane (canalicular)33/53 (62.3)12/14 (85.7)19/35 (54.3)2/4 (50.0)0/32
HepPar129/53 (54.7)10/14 (71.4)19/35 (54.3)0/41/32 (3.1)
AFP17/53 (32.1)2/14 (14.3)12/35 (34.3)3/4 (75.0)0/32